Half-year report · Q2
9438.TEDINET S100VRCD
Period2024-10-01 → 2025-03-31
Filed2025-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.9bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥27.7bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.5bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥1.6bn | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.5bn | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.2bn | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥1.6bn | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥30.7bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥29.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥29.2bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.1bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥10.5bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥20.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥19.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥18.7bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.8bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.7bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.0bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.1bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥789m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥609m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥770m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.6bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥928m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥31.87 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.05 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.41 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥31.82 | 2024-10-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.02 | 2023-10-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.41 | 2023-10-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 54.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥723m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥723m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥1.3bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥8.7bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥8.5bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥108m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥2.0bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥3.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥3.1bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥5m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥87m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥2.9bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥2.3bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥609m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥629m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥904m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥904m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥272m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥15.6bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥14.9bn |
| —segment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥723m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥3.0bn |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥698m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥698m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥1.2bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥8.4bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥8.4bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥76m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥2.3bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥2.6bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥2.6bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥4m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥217m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥2.7bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥2.0bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥617m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥37m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥521m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥521m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥157m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥14.2bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥13.5bn |
| —segment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥698m |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥2.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 541
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss | CurrentYTDDuration | 1818940000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 1321000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -6531000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 1964000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 828000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -3268000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -8082000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 31177000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 22459000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 31194000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 8674000 | JPY |
| Comprehensive income | Prior1YTDDuration | 1650335000 | JPY |
| Comprehensive income | CurrentYTDDuration | 1827614000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 1589981000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 1765900000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 60354000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 61713000 | JPY |
| Income before income taxes | Prior1YTDDuration | 2225418000 | JPY |
| Income before income taxes | CurrentYTDDuration | 2547707000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 732111000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 657843000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | 39446000 | JPY |
| Impairment loss ope cf | CurrentYTDDuration | － | JPY |
| Loss gain on transfer of business ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on transfer of business ope cf | CurrentYTDDuration | 3113000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 98532000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 30621000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | 216000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -2568000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 50906000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 83383000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -50000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -1416000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 4628000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 8510000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | -510833000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | -92216000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YTDDuration | -278000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYTDDuration | -337000 | JPY |
| Loss on retirement of noncurrent assets ope cf | Prior1YTDDuration | 8049000 | JPY |
| Loss on retirement of noncurrent assets ope cf | CurrentYTDDuration | 604000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YTDDuration | 31672000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYTDDuration | 7051000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | -22500000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -321209000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -518112000 | JPY |
| Increase decrease in contract liabilities ope cf | Prior1YTDDuration | -430560000 | JPY |
| Increase decrease in contract liabilities ope cf | CurrentYTDDuration | -659553000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -4946000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |